Arrhythmogenic right ventricular cardiomyopathy/dysplasia: An update

Current Cardiology Reports

Volumn 10, Issue 5, 2008, Pages 367-375

  Calkins, Hugh ^a   Marcus, Frank ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONTRAST MEDIUM; DESMIN; DESMOCOLLIN; DESMOGLEIN; DESMOGLEIN 2; DESMOPLAKIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLAKOGLOBIN; PLAKOPHILIN; RYANODINE RECEPTOR; SOTALOL; TRANSFORMING GROWTH FACTOR BETA3;

ANGIOCARDIOGRAPHY; ARRHYTHMOGENESIS; AUTOSOMAL DOMINANT INHERITANCE; CATHETER ABLATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEFIBRILLATOR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ECG ABNORMALITY; ECHOCARDIOGRAPHY; EPICARDIUM MAPPING; GENE MUTATION; GENETIC POLYMORPHISM; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HUMAN; IMPLANTATION; MEDICAL DECISION MAKING; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SENSITIVITY AND SPECIFICITY; THERAPY EFFECT; TREATMENT RESPONSE; ARTICLE; CONGENITAL MALFORMATION; DESMOSOME; ELECTROCARDIOGRAPHY; GENETICS; HEART ARRHYTHMIA; HEART VENTRICLE; PATHOPHYSIOLOGY; SURVIVOR;

ARRHYTHMIAS, CARDIAC; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; DESMOSOMES; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; HEART VENTRICLES; HUMANS; SURVIVORS;

EID: 58149132138     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-008-0059-4     Document Type: Review

References (51)

1. Corrado D, Basso C, Thiene G: Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 2001, 50: 399-408.
2. Tester D, Ackerman MJ: The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 2006, 21: 166-172.
3. Dalal D, Nasir K, Bomma C, et al.: Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation 2005, 112: 3823-3832.
4. McKenna WJ, Thiene G, Nava A, et al.: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994, 71: 215-218.
5. Nasir K, Bomma C, Tandri H, et al.: Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: A need to broaden diagnostic criteria. Circulation 2004, 110: 1527-1534.
6. Marcus FI: Prevalence of T-wave inversion beyond V(1) in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Am J Cardiol 2005, 95: 1070-1071.
7. Cox M, Nelen M, Wilde A, et al.: Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Towards improvement of diagnostic ECG criteria. J Cardiovasc Electrophysiol 2008 Mar 26 (Epub ahead of print).
8. Nasir K, Rutberg J, Tandri H, et al.: Utility of SAECG in arrhythmogenic right ventricle dysplasia. Ann Noninvasive Electrocardiol 2003, 8: 112-120.
9. Nasir K, Bomma C, Khan FA, et al.: Utility of a combined signal-averaged electrocardiogram and QT dispersion algorithm in identifying arrhythmogenic right ventricular dysplasia in patients with tachycardia of right ventricular origin. Am J Cardiol 2003, 92: 105-109.
10. Indik J, Wichter T, Gear K, et al.: Quantitative assessment of angiographic right ventricular wall motion in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). J Cardiovasc Electrophysiol 2008, 19: 39-45.
11. Yoerger DM, Marcus F, Sherrill D, et al.: Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: New insights from the multidisciplinary study of right ventricular dysplasia. J Am Coll Cardiol 2005, 45: 860-865.
12. Prakasa KR, Wang J, Tandri H, et al.: Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Am J Cardiol 2007, 100: 507-512.
13. Tandri H, Calkins H, Nasir K, et al.: Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2003, 14: 476-482.
14. Tandri H, Friedrich MG, Calkins H, Bluemke DA: MRI of arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Magn Reson 2004, 6: 557-563.
15. Bluemke DA, Krupinski EA, Ovitt T, et al.: MR imaging of arrhythmogenic right ventricular cardiomyopathy: Morphologic findings and interobserver reliability. Cardiology 2003, 99: 153-162.
16. Tandri H, Saranathan M, Rodriguez ER, et al.: Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005, 45: 98-103.
17. Tandri H, Bomma C, Calkins H, Bluemke DA: Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J Magn Reson Imaging 2004, 19: 848-858.
18. Tandri H, Castillo E, Ferrari VA, et al.: Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: Sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006, 48: 2277-2284.
19. Tandri H, Calkins H, Marcus FI: Controversial role of magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular dysplasia. Am J Cardiol 2003, 92: 649.
20. Bomma C, Rutberg J, Tandri H, et al.: Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 2004, 15: 300-306.
21. Macedo R, Prakasa K, Tichnell C, et al.: Marked lipomatous infiltration of the right ventricle: MRI findings in relation to arrhythmogenic right ventricular dysplasia. AJR Am J Roentgenol 2007, 188: W423-W427.
22. Shiraishi J, Tatsumi T, Shimoo K, et al.: Cardiac sarcoidosis mimicking right ventricular dysplasia. Circ J 2003, 67: 169-171.
23. Bomma C, Dalal D, Tandri H, et al.: Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol 2007, 100: 99-105.
24. O'Donnell D, Cox D, Bourke J, et al.: Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J 2003, 24: 801-810.
25. Boulos M, Lashevsky I, Reisner S, et al.: Electroanatomic mapping of arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol 2001, 38: 2020-2027.
26. Boulos M, Lashevsky I., Gepstein L: Usefulness of electroanatomical mapping to differentiate between right ventricular outflow tract tachycardia and arrhythmogenic right ventricular dysplasia. Am J Cardiol 2005, 95: 935-940.
27. Miljoen H, State S, de Chillou C, et al.: Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Europace 2005, 7: 516-524.
28. Corrado D, Basso C, Leoni L: Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2005, 111: 3042-3050.
29. Corrado D, Basso C, Leoni L: Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol 2008, 51: 731-739.
30. Bauce B, Basso C, Rampazzo A, et al.: Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 2005, 26: 1666-1675.
31. Sen-Chowdhry S, Syrris P, Ward D, et al.: Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007, 115: 1710-1720.
32. Hamid MS, Norman M, Quraishi A, et al.: Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/ dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002, 40: 1445-1450.
33. Tandri H, Bluemke DA, Ferrari VA, et al.: Findings on magnetic resonance imaging of idiopathic right ventricular outflow tachycardia. Am J Cardiol 2004, 94: 1441-1445.
34. Ainsworth CD, Skanes AC, Klein GJ, et al.: Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis. Heart Rhythm 2006, 4: 416-423.
35. Tandri H, Asimaki A, Dalal D, et al.: A case of arrhythmogenic right ventricular dysplasia due to plakophilin-2 mutation: Arrhythmic, structural and functional deterioration leading to transplantation. J Cardiovasc Res 2008 (in press).
36. Sen-Chowdhry S, Syrris P, McKenna WJ: Genetics of right ventricular cardiomyopathy. J Cardiovasc Electrophysiol 2005, 16: 927-935.
37. Awad M, Calkins HA Judge D: Mechanisms of disease: a molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract 2008, 1: 1-10.
38. Merner N, Hodgkinson KA, Haywood A, et al.: Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 2008, 82: 809-821.
39. Piccini JP, Dalal D, Roguin A, et al.: Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2005, 2: 1188-1194.
40. Wichter T, Paul M, Wollmann C, et al.: Implantable cardioverter/ defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004, 109: 1503-1508.
41. Corrado D, Leoni L, Link MS, et al.: Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003, 108: 3084-3091.
42. Roguin A, Bomma CS, Nasir K, et al.: Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004, 43: 1843-1852.
43. Hiroi Y, Fujiu K, Komatsu S, et al.: Carvedilol therapy improved left ventricular function in a patient with arrhythmogenic right ventricular cardiomyopathy. Jpn Heart J 2004, 45: 169-177.
44. Buja G, Estes M, Wichter T, et al.: Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Risk stratification and therapy. Prog Cardiovasc Dis 2008, 50: 282-293.
45. Zou J, Cao K, Yang B, et al.: Dynamic substrate mapping and ablation of ventricular tachycardias in right ventricular dysplasia. J Interv Card Electrophysiol 2004, 11: 37-45.
46. Dalal D, Jain R, Tandri H, et al.: Long term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2007, 50: 432-440.
47. Satomi K, Kurita T, Suyama K, et al.: Catheter ablation of stable and unstable ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2006, 17: 469-476.
48. Lacroix D, Lions C, Klug D, Prat A: Arrhythmogenic right ventricular dysplasia: Catheter ablation, MRI, and heart transplantation. J Cardiovasc Electrophysiol 2005, 16: 235-236.
49. Yao Y, Zhang S, Sheng D, et al.: Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping. Pacing Clin Electrophysiol 2007, 30: 526-533.
50. Severini GM, Krajinovic M, Pinamonti B, et al.: A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 1996, 31: 193-200.
51. Heuser A, Plovie ER, Ellinor PT, et al.: Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2006, 79: 1081-1088.